We found that tumor-infiltrating leukocytes, including macrophages M0/M1/M2, T cell CD4+ naïve, Tregs, monocyte, neutrophil, and NK activated, differed significantly between the different risk subgroups. The gene discussed is CD4; the disease is neoplasm.